CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 130 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $62,424,293 | -32.5% | 1,734,972 | -16.4% | 1.41% | -24.7% |
| Q4 2022 | $92,482,750 | +58.6% | 2,075,000 | 0.0% | 1.88% | +50.8% |
| Q3 2022 | $58,328,000 | +4.3% | 2,075,000 | 0.0% | 1.24% | -16.6% |
| Q2 2022 | $55,942,000 | -20.8% | 2,075,000 | 0.0% | 1.49% | -3.2% |
| Q1 2022 | $70,675,000 | +1.3% | 2,075,000 | +15.0% | 1.54% | +25.4% |
| Q4 2021 | $69,737,000 | -19.3% | 1,804,795 | +12.8% | 1.23% | +2.8% |
| Q3 2021 | $86,384,000 | +1549.8% | 1,600,000 | +353.2% | 1.20% | +1146.9% |
| Q3 2020 | $5,236,000 | -65.0% | 353,072 | -69.3% | 0.10% | -67.0% |
| Q2 2020 | $14,950,000 | – | 1,150,000 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 2,600,000 | $88,218,000 | 12.13% |
| Octagon Capital Advisors LP | 759,898 | $25,783,339 | 3.59% |
| TSP Capital Management Group, LLC | 251,895 | $8,546,800 | 3.08% |
| ACUTA CAPITAL PARTNERS, LLC | 122,343 | $4,151,098 | 2.81% |
| 5AM Venture Management, LLC | 310,270 | $10,527,461 | 2.62% |
| COMMODORE CAPITAL LP | 631,665 | $21,432,393 | 2.41% |
| RTW INVESTMENTS, LP | 3,463,201 | $117,506,410 | 2.24% |
| Eversept Partners, LP | 785,740 | $26,660,158 | 2.23% |
| Redmile Group, LLC | 1,696,004 | $57,545,416 | 2.21% |
| Affinity Asset Advisors, LLC | 87,031 | $2,952,962 | 1.03% |